Javascript must be enabled to continue!
The Impact of Syphilis on HIV Acquisition and Progression in Sub-Saharan Africa
View through CrossRef
Most people living with HIV (PLWH) are co-infected with syphilis or other sexually transmitted infections (STIs) and experience frequent reactivations of syphilis. Thus, syphilis or other STIs are highly prevalent in most regions experiencing severe HIV epidemics. In sub-Saharan Africa, the region most heavily affected by HIV, the prevalence of syphilis among PLWH is approximately 7.3%. This region accounts for 40% of global STIs and 70% of HIV cases, highlighting the need for targeted research. Despite the high prevalence of syphilis among PLWH in the region, the impact of syphilis on HIV transmission and HIV disease progression has not been well-studied. In this manuscript, we evaluated if syphilis facilitates HIV acquisition and HIV disease progression in the region. We used retrospective data from 53,915 adult participants enrolled through Population-based HIV Impact Assessment (PHIA) surveys conducted in Zambia and Tanzania. Logistic regression models were used to assess the impact of syphilis on HIV acquisition and disease progression. Our findings indicated that syphilis infection was associated with higher odds of HIV acquisition. Moreover, co-infection with syphilis was associated with higher odds of HIV disease progression among PLWH treated with antiretroviral therapy (ART). Our findings suggested that the recognition, treatment, and prevention of syphilis to reduce the risk of HIV transmission and HIV disease progression should be a public health priority in sub-Saharan Africa, where ART may not be readily available.
Title: The Impact of Syphilis on HIV Acquisition and Progression in Sub-Saharan Africa
Description:
Most people living with HIV (PLWH) are co-infected with syphilis or other sexually transmitted infections (STIs) and experience frequent reactivations of syphilis.
Thus, syphilis or other STIs are highly prevalent in most regions experiencing severe HIV epidemics.
In sub-Saharan Africa, the region most heavily affected by HIV, the prevalence of syphilis among PLWH is approximately 7.
3%.
This region accounts for 40% of global STIs and 70% of HIV cases, highlighting the need for targeted research.
Despite the high prevalence of syphilis among PLWH in the region, the impact of syphilis on HIV transmission and HIV disease progression has not been well-studied.
In this manuscript, we evaluated if syphilis facilitates HIV acquisition and HIV disease progression in the region.
We used retrospective data from 53,915 adult participants enrolled through Population-based HIV Impact Assessment (PHIA) surveys conducted in Zambia and Tanzania.
Logistic regression models were used to assess the impact of syphilis on HIV acquisition and disease progression.
Our findings indicated that syphilis infection was associated with higher odds of HIV acquisition.
Moreover, co-infection with syphilis was associated with higher odds of HIV disease progression among PLWH treated with antiretroviral therapy (ART).
Our findings suggested that the recognition, treatment, and prevention of syphilis to reduce the risk of HIV transmission and HIV disease progression should be a public health priority in sub-Saharan Africa, where ART may not be readily available.
Related Results
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
OSPHL in collaboration with APHL, will evaluate the performance of the Oxford Nanopore Technology sequencers for HIV genome sequencing using a modified protocol of the ARTIC amplic...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Laboratory-Based Evaluation of SD Bioline HIV/Syphilis Duo Rapid Test Kits in the Gambia, November 2019
Laboratory-Based Evaluation of SD Bioline HIV/Syphilis Duo Rapid Test Kits in the Gambia, November 2019
Background: HIV and syphilis are mainly diagnosed using separate rapid test kits for the HIV counseling and testing (HCT), Prevention of Mother-to-Child Transmission of HIV (PMTCT)...
HIV, syphilis and hepatitis B coinfections in Mkushi, Zambia: a cross-sectional study
HIV, syphilis and hepatitis B coinfections in Mkushi, Zambia: a cross-sectional study
ABSTRACT
Background:
Human Immunodeficiency Virus, syphilis and Hepatitis B Virus are major global pub...
Epidemiological, diagnostic and medical-social aspects of latent syphilis
Epidemiological, diagnostic and medical-social aspects of latent syphilis
Objective — to study epidemiological, clinical and medical-social aspects of latent syphilis in Ukraine over the past 40 years.
Materials and methods. Data of patients with latent ...
Field validation and application of the luminex triplex HIV assay to estimate HIV prevalence and HIV-1 incidence in Nigeria
Field validation and application of the luminex triplex HIV assay to estimate HIV prevalence and HIV-1 incidence in Nigeria
HIV cross-sectional surveys require multi-layered testing with several tests to estimate HIV prevalence and HIV-1 incidence. We evaluated the performance and accuracy of the newly ...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...

